A Study of A-101 Topical Solution for the Treatment of Common Warts
Public ClinicalTrials.gov record NCT03691831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 3 Study of A-101 Topical Solution in Subjects with Common Warts
Study identification
- NCT ID
- NCT03691831
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 502 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 12, 2018
- Primary completion
- Apr 20, 2019
- Completion
- Jul 8, 2019
- Last update posted
- Oct 26, 2020
2018 – 2019
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigational Site | Glendale | Arizona | 85308 | — |
| Aclaris Investigational Site | Fort Smith | Arkansas | 72916 | — |
| Aclaris Investigational Site | Encinitas | California | 92024-7700 | — |
| Aclaris Investigational Site | San Diego | California | 92121 | — |
| Aclaris Investigational Site | Denver | Colorado | 80210 | — |
| Aclaris Investigational Site | Coral Gables | Florida | 33134 | — |
| Aclaris Investigational Site | Miami | Florida | 33155 | — |
| Aclaris Investigational Site | New Albany | Indiana | 47150 | — |
| Aclaris Investigational Site | Rockville | Maryland | 20850 | — |
| Aclaris Investigational Site | Quincy | Massachusetts | 02169 | — |
| Aclaris Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Aclaris Investigational Site | Omaha | Nebraska | 68144 | — |
| Aclaris Investigational Site | Rochester | New York | 14623 | — |
| Aclaris Investigational Site | Raleigh | North Carolina | 27612 | — |
| Aclaris Investigational Site | Beachwood | Ohio | 44122 | — |
| Aclaris Investigational Site | Upper Saint Clair | Pennsylvania | 15241 | — |
| Aclaris Investigational Site | Anderson | South Carolina | 29621 | — |
| Aclaris Investigational Site | Knoxville | Tennessee | 37922 | — |
| Aclaris Investigational Site | Nashville | Tennessee | 37215 | — |
| Aclaris Investigational Site | Arlington | Texas | 76011 | — |
| Aclaris Investigational Site | College Station | Texas | 77845 | — |
| Aclaris Investigational Site | Houston | Texas | 77004 | — |
| Aclaris Investigational Site | Lynchburg | Virginia | 24501 | — |
| Aclaris Investigational Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03691831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2020 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03691831 live on ClinicalTrials.gov.